TrialJCO oncology practice2026

Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors.

Charlene M Mantia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.